|Title||Rapid detection of SARS-CoV-2 variants of concern by single nucleotide polymorphism genotyping using TaqMan assays.|
|Publication Type||Journal Article|
|Year of Publication||2022|
|Authors||Velu P, Cong L, Rand S, Qiu Y, Zhang Z, Zhang J, Guo J, Ruggiero P, Sukhu A, Fauntleroy K, Imada E, Zanettini C, Brundage D, Westblade L, Marchionni L, Cushing MM, Rennert H|
|Journal||Diagn Microbiol Infect Dis|
|Date Published||2022 Dec|
|Keywords||COVID-19, COVID-19 Testing, Genotype, Humans, Mutation, Polymorphism, Single Nucleotide, SARS-CoV-2|
We evaluated the performance of SARS-CoV-2 TaqMan real-time reverse-transcription PCR (RT-qPCR) assays (ThermoFisher) for detecting 2 nonsynonymous spike protein mutations, E484K and N501Y. Assay accuracy was evaluated by whole genome sequencing (WGS). Residual nasopharyngeal SARS-CoV-2 positive samples (N = 510) from a diverse patient population in New York City submitted for routine SARS-CoV-2 testing during January-April 2020 were used. We detected 91 (18%) N501Y and 101 (20%) E484K variants. Four samples (0.8%) were positive for both variants. The assay had nearly perfect concordance with WGS in the validation subset, detecting B.1.1.7 and B.1.526 variants among others. Sensitivity and specificity ranged from 0.95 to 1.00. Positive and negative predictive values were 0.98-1.00. TaqMan genotyping successfully predicted the presence of B.1.1.7, but had significantly lower sensitivity, 62% (95% CI, 0.53, 0.71), for predicting B.1.526 sub-lineages lacking E484K. This approach is rapid and accurate for detecting SARS-CoV-2 variants and can be rapidly implemented in routine clinical setting.
|Alternate Journal||Diagn Microbiol Infect Dis|
|PubMed Central ID||PMC9392658|
Luigi Marchionni, M.D., Ph.D. Priya Velu, M.D., Ph.D. Lars Westblade, Ph.D. Melissa Cushing, M.D. Hanna Rennert, Ph.D.